drugset / Trial / NCT02022540
Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD
RandomizedParallel-groupOpen-labelTreatment
Summary
The objective of this study is to assess the safety and tolerability of topical ocular PAN-90806 in patients with active, subfoveal choroidal neovascularization associated with neovascular Age-Related Macular Degeneration (AMD).
Timeline
- Start
- 2014-02
- Primary completion
- 2016-03
- Completion
- 2016-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | OSI-632 | Small molecule | — | Topical |
| Background | Ranibizumab | Monoclonal antibody | — | Intravitreal |